AHR and ovarian carcinoma: It is expressed in human ovarian cancer, and the endogenous AHR ligand, 2-(1'H-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE), inhibits ovarian cancer cell proliferation and migration in vitro [19].